Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2024 second quarter results at 7 a.m. ET on Thursday, March 28, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens.

Walgreens Boots Alliance Schedules Fiscal 2024 Second Quarter Earnings Announcement for March 28

Apple

Ares Commercial Real Estate

Agree Realty

American Tower

Medical Properties Trust

NVIDIA

Realty Income Corp

Prologis

Simon Property Group

Vici Properties

Real Estate Select Sector SPDR Fund

Dividend stocks, particularly REITs, have underperformed the broader market due to interest rate hikes. The suppressed share prices of REITs present a short-lived opportunity for dividend investors to take advantage of. Investing in high-quality companies with strong fundamentals is important for long-term success in the dividend investing strategy.

Why Dividend Investors Should Be Smiling

British American Tobacco

Innovative Industrial Properties

Sometimes, investing can be daunting, especially for new investors. They have many options to lose money, but they can make a fortune with sharp selections.

3 Starter Dividend Stocks Every New Investor Should Own

Automatic Data Processing

Aflac

Best Buy

Blackstone Secured Lending Fund

Comcast

CME Group

Duke Energy

Enterprise Products Partners

Home Depot

Hershey

Intercontinental Exchange

MarketAxess Holdings

NextEra Energy

Nexstar Media Group

Omega Healthcare Investors

PepsiCo

Prudential Financial

Snap-on

Williams-Sonoma

As we reach the 15th anniversary of the 2009 market lows, I am thankful to be a dividend growth investor. February brought several dividend increases to the portfolio, but there will be none in March. While the market as a whole is overvalued, several high-quality dividend growth companies look interesting at today's prices.

My Dividend Growth Portfolio February Update

Walgreens Boots Alliance (WBA) concluded the recent trading session at $21.24, signifying a +0.38% move from its prior day's close.

Walgreens Boots Alliance (WBA) Increases Yet Falls Behind Market: What Investors Need to Know

Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.

Investors Heavily Search Walgreens Boots Alliance, Inc. (WBA): Here is What You Need to Know

Amazon

SPDR Dow Jones Industrial Average ETF

Invesco Dow Jones Industrial Average Dividend ETF

First Trust Dow 30 Equal Weight ETF

iShares Dow Jones U.S. ETF

Microsoft

Walmart

Amazon.com (AMZN) joined the Dow Jones, replacing drugstore operator Walgreens Boots Alliance (WBA) on Feb 26. The reshuffle reflects the ongoing shift from traditional brick-and-mortar retail to e-commerce and technology-driven companies.

ETFs in Focus as Amazon Enters Dow Jones

DEERFIELD, Ill.--(BUSINESS WIRE)--Today, Walgreens announced it is the first community pharmacy to accept a broad array of Medicare Advantage supplemental benefits online, through Walgreens.com and the Walgreens app. Eligible members can now shop from a catalog of approximately 1,700 Shop Eligible Products on Walgreens digital channels. Consumers have been able to shop using their Medicare Advantage supplemental benefits in stores since 2019 and this brings even greater convenience with new dig.

Walgreens First Community Pharmacy to Accept a Broad Array of Medicare Advantage Supplemental Benefits Online and in App

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today named Lanesha Minnix the company's executive vice president (EVP) and global chief legal officer. Minnix, most recently EVP, general counsel and corporate secretary for Ecolab, Inc., will assume her new role with WBA on April 15. Minnix, who will report to WBA CEO Tim Wentworth and serve on his Executive Committee, will oversee the company's global legal, compliance, corporate governance and corporate security.

Walgreens Boots Alliance Names Lanesha Minnix Executive Vice President and Global Chief Legal Officer

Amazon.com Inc. is joining the ranks of one of Wall Street's oldest and most exclusive stock indexes: The Dow Jones Industrial Average.

Amazon in, Walgreens out at Dow Jones

One analyst just dropped their price target for Walgreens Boots Alliance. It wasn't the first time the analyst adjusted her expectations downwards.

Is Walgreens Boots Alliance Stock Going to $20? 1 Wall Street Analyst Thinks So.

The keepers of the Dow Jones Industrial Average have been very good at making sure the changes they make to the venerable stock-market barometer are seamless to investors, but nobody's perfect.

Amazon's stock could lose to Walgreens' this year if the Dow jinx holds

Walgreens Boots Alliance is in the midst of a transition. New CEO Tim Wentworth is exploring all options for the business.

Is Walgreens Boots Alliance Stock a Buy Now?

Amazon joins the elite club of Dow Jones stocks, while troubled Walgreens gets the boot.

Amazon to Replace Walgreens in the Dow: Why This Matters

Amazon.com Inc. (AMZN) rose 1% in early trading Wednesday following news that the online retailing giant is set to join the Dow Jones Industrial Average, replacing pharmacy chain Walgreens Boots Alliance (WBA).

Amazon To Join the Dow Jones Industrial Average, Replacing Walgreens

Walgreens (NASDAQ: WBA ) stock is sinking 2% in early trading after S&P Global announced that the pharmaceuticals retailer would be removed from the Dow Jones Industrial Average (DJIA), effective Feb. 26. Amazon (NASDAQ: AMZN ) will replace WBA stock in the Dow Jones index on that day.

Goodbye, Walgreens! WBA Stock Slips as It Exits Dow Jones

The first shakeup to the Dow Jones Industrial Average in nearly six years will happen on Monday. That's when Amazon will join the Dow and Walgreens will be removed from the index.

Amazon is replacing Walgreens on the Dow Jones: Why it's happening and how it works

Shares of Walgreens Boots Alliance fell 3% in premarket trading on Wednesday after the U.S. pharmacy chain operator lost its spot on the Dow Jones Industrial Average to Amazon , after nearly three years on the blue-chip stock index.

Walgreens shares fall after losing spot in blue-chip Dow index

Amazon.com Inc (NASDAQ:AMZN, ETR:AMZ) is set to replace Walgreens Boots Alliance in the Dow Jones Industrial Average (DJIA) index to reflect “the evolving nature of the American economy”, Standard & Poors has announced. Effective Monday, 26 February, the swap will “increase retail business exposure as well as other business areas” in the 128-year-old index, and was promoted by Walmart's decision to conduct a 3:1 split on its stock price.

Amazon replaces Walgreens in Dow Jones Industrial Average index

New CEO Tim Wentworth has made some unpopular decisions, including cutting the dividend, but there are potential silver linings. Even after accounting for the reduced payout, the yield is still better than what average staple stocks currently offer. WBA is on course to generate $2bn of savings via the dividend cut, reduced CAPEX, working capital improvements, and a leaner cost base.

Walgreens Boots Alliance: Offers Some Promise

Fiverr

Alphabet

Though volatility has ruled the roost on Wall Street for the past four years, deals can still be found. Most online brokers have done away with barriers that previously kept retail investors on the sidelines.

3 No-Brainer Stocks to Buy With $400 Right Now

In another change, Uber will replace JetBlue in the Dow Jones Transportation Average.

Amazon to Join Dow Industrials, Replacing Walgreens

Walgreens Boots Alliance sold some of its shares of Cencora. The sale is only the latest in a series of moves to shore up its liquidity.

Walgreens Boots Alliance Just Made $992 Million. Here's Why That's Not Good News.

Hasbro

Plug Power

Tesla

ViaSat

Short selling, however, isn't for the faint of heart.

6 Stocks to Consider Shorting, According to an Analyst

NIKE

UnitedHealth Group

The Dow Jones Industrial Average is near record highs as the stock rally that began in spring 2023 continues. Comprised of 30 leading blue-chip stocks that are representative of the U.S. economy, the index is often referred to as the “Dow 30.

News for Walgreens Stock (WBA)